Bio logo
Enablers Making it

Anglia Ruskin University, Cambridge

15 May 2024

Bio Integrates 2024

Anglia Ruskin University, Cambridge, 15 May 2024

Engage with top executives in biotech, CDMO, supply chain, and funding & investment to discuss the major challenges impacting the Biotech sector.

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS

PLEASE NOTE The timings have not been finalised so maybe subject to change.

 


 

Headline Sponsor:

Gold Sponsors:

Silver Sponsor:

Mills-Reeve-Logo    

 

Bronze Sponsors:

                

                 

           

 

Registration & Networking

08:30 – 09:30

Registration and networking

Welcome & Opening Remarks

09:30 – 09:45

Introduction

Opening Remarks

Martino Picardo
Chairman, Discovery Park

Yvonne Barnett
Deputy Vice Chancellor
(Research and Innovation),
Anglia Ruskin University

Fireside Chat 1

09:45 – 10:05

Fireside Chat 1

Philip Cruz
Country Medical Director UK,
Moderna

Interviewed by:

Martino Picardo
Chairman, Discovery Park

 

 

Fireside Chat 2

10:05 – 10:25

Fireside Chat 2

Melanie Lee
Founder, Think10

Interviewed by:

Martino Picardo
Chairman, Discovery Park

 

 

ENABLERS

Discussing key factors in the wider biotech ecosystem – other than the science – that underpin success

MAKING IT

On the tools, techniques and strategies to bring biotech innovations to the market

Session 1

10:30 – 11:20

Money in, money out

In a competitive market, how do you stand out to attract investors? How can your IP strategy enable you to gain market share, attract more investments, and create a meaningful ROI?

Facilitated by:

Jenny Laird
VP, Search & Evaluation Neuroscience, Eli Lilly

Panellists Include:

Marc Wilkinson
Partner, UK & European Patent Attorney, Patent Attorney Litigator, J A Kemp

Bradley Hardiman
Senior Director, Ventures – Business Development, Astellas Pharma Europe

Camilla Easter
CEO, Oxford Medical Products

Katharine Robinson
Principal Associate at Mills & Reeve LLP

Alex Brown
Sr. Investment Associate,

Intelligent Artificial Intelligence

AI is very much a buzzword across industries, including the biotech industry. How can we adopt an intelligent AI strategy to maximise benefits and minimise risks?

Facilitated by:

James Fry
Partner and Head of Life Sciences Practice at Mills & Reeve

Panellists include:

Joshua Blight
Co-Founder & CEO, Baseimmune

Dean Plumbley
CTO and Head of AI, CoSyne Therapeutics

Alison Jones
Science Director, Chemistry, Charles River Laboratories

Martin-Immanuel Bittner
Co-Founder & CEO, Arctoris

Sam Windsor
Chief Executive Officer, Ignota Labs

Networking Coffee Break

11:20 – 11:50

Networking Coffee Break

Session 2

11:50 – 12:20

Removing the ‘late’ from ‘regulate’ – the benefits of engaging early

As biotech products become increasingly innovative, it’s essential to engage with regulators. How can engaging with regulators early and often help you overcome hurdles, understand data requirements, and maximise the benefits of innovation?

Facilitated by:

Kathryn Simpson
Director, Kathryn Simpson Consulting Limited

Panellists Include:

Vineeta Tripathi

CEO, CSO, Vitarka Therapeutics

Suzanne Dilly 
Chief Executive Officer at VALIRX PLC

Moein Moghimi
Professor of Pharmaceutics and Nanomedicine, Newcastle University

From lab to large-scale

New technologies enable drugs to be manufactured more efficiently, more compliantly, and at a lower cost. What is the role of advanced, automated, data-controlled processes in the future of biopharmaceutical manufacturing?

Panellists include:

Richard Vellacott
Chief Executive Officer, BiologIC Technologies

Amrik Basran
Chief Discovery Officer, Turbine AI

Neil Wetherall
Managing Director, Factorytalk UK

Session 3

12:25 – 13:15

The place to be

The UK has a strong network of biotech hubs, science parks, and innovation hotspots. How do you choose your location to maximise your growth?

Facilitated by:

Bev Vaughan
Arise Innovation Hubs Director, Anglia Ruskin University

Panellists include:

Mayer Schreiber
Chief Executive Officer, Discovery Park

Nuno Alves
Associate Director – Business Development, Astellas Europe

Steven Trim
Director, Venomtech Ltd

Rich Ferrie
Chief Executive Officer, London BioScience Innovation Centre (LBIC)

Kristin Anne Rutter
Executive Director, Cambridge University Health Partners

Networking Lunch

13:15 – 14:15

Networking Lunch

Session 4

14:15 – 15:05

Productive partnerships

When time is money, an efficient partnership can be the key to success. What is the key to a healthy partnership between a biotech and CDMO/CMO, and how do partnerships evolve with the changing needs of a growing biotech?

Facilitated by:

Nathalie Huther
Associate Vice President Business Development (CMC),

Panellists include:

Justin Bryans
Chief Scientific Officer (Discovery), Charles River Laboratories

Kevin Cox
Chairman, VALIRX PLC

Helen Barker
Vice President, Global Tech Ops & CMC, Reneo Pharmaceuticals

Kwok Pang
Chief Digital Officer, Adthera Bio

Neil Jones
Chief Commercial Officer, Aenova Group

Session 5

15:10 – 16:00

The workforce of the future

What should the biotech workforce of the future look like? How can we develop new skills and embrace diverse ways of thinking to build a better biotech sector?

Facilitated by:

Hardeep Jhutty
Director of R&D Strategic Operations,

Panellists include:

Claire Pike
Pro Vice-Chancellor (Education Enhancement) and Professor, Anglia Ruskin University

Shadi Farhangrazi
Chief Executive Officer, S.M. Discovery Group (SMDG)

Lydia Mapstone
CEO and Co-founder at BoobyBiome

Philip Probert
Biologics Technology Lead, CPI

Networking Drinks

16:00 – 17:00

Drinks Reception

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Enablers Making it

Anglia Ruskin University, Cambridge

15 May 2024

Bio logo
Enablers Making it

Anglia Ruskin University, Cambridge

15 May 2024

Bio Integrates 2024

Anglia Ruskin University, Cambridge, 15 May 2024

Engage with top executives in biotech, CDMO, supply chain, and funding & investment to discuss the major challenges impacting the Biotech sector.

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS

PLEASE NOTE The timings have not been finalised so maybe subject to change.

 


 

Headline Sponsor:

Gold Sponsors:

Silver Sponsor:

Mills-Reeve-Logo    

 

Bronze Sponsors:

                

                 

           

 

ENABLERS

Discussing key factors in the wider biotech ecosystem – other than the science – that underpin success

MAKING IT

On the tools, techniques and strategies to bring biotech innovations to the market

Registration & Networking

08:30 – 09:30

Welcome & Opening Remarks

09:30 – 09:45

Fireside Chat 1

09:45 – 10:05

Fireside Chat 2

10:05 – 10:25

10:30 – 11:20
Session 1

Track one:

Money in, money out

In a competitive market, how do you stand out to attract investors? How can your IP strategy enable you to gain market share, attract more investments, and create a meaningful ROI?

Facilitated by:

Jenny Laird
VP, Search & Evaluation Neuroscience, Eli Lilly

Panellists Include:

Marc Wilkinson
Partner, UK & European Patent Attorney, Patent Attorney Litigator, J A Kemp

Bradley Hardiman
Senior Director, Ventures – Business Development, Astellas Pharma Europe

Camilla Easter
CEO, Oxford Medical Products

Katharine Robinson
Principal Associate at Mills & Reeve LLP

Alex Brown
Sr. Investment Associate,

Track two:

Intelligent Artificial Intelligence

AI is very much a buzzword across industries, including the biotech industry. How can we adopt an intelligent AI strategy to maximise benefits and minimise risks?

Facilitated by:

James Fry
Partner and Head of Life Sciences Practice at Mills & Reeve

Panellists include:

Joshua Blight
Co-Founder & CEO, Baseimmune

Dean Plumbley
CTO and Head of AI, CoSyne Therapeutics

Alison Jones
Science Director, Chemistry, Charles River Laboratories

Martin-Immanuel Bittner
Co-Founder & CEO, Arctoris

Sam Windsor
Chief Executive Officer, Ignota Labs

Networking Coffee

11:20 – 11:50

11:50 – 12:20
Session 2

Track one:

Removing the ‘late’ from ‘regulate’ – the benefits of engaging early

As biotech products become increasingly innovative, it’s essential to engage with regulators. How can engaging with regulators early and often help you overcome hurdles, understand data requirements, and maximise the benefits of innovation?

Facilitated by:

Kathryn Simpson
Director, Kathryn Simpson Consulting Limited

Panellists Include:

Vineeta Tripathi

CEO, CSO, Vitarka Therapeutics

Suzanne Dilly 
Chief Executive Officer at VALIRX PLC

Moein Moghimi
Professor of Pharmaceutics and Nanomedicine, Newcastle University

Track two:

From lab to large-scale

New technologies enable drugs to be manufactured more efficiently, more compliantly, and at a lower cost. What is the role of advanced, automated, data-controlled processes in the future of biopharmaceutical manufacturing?

Panellists include:

Richard Vellacott
Chief Executive Officer, BiologIC Technologies

Amrik Basran
Chief Discovery Officer, Turbine AI

Neil Wetherall
Managing Director, Factorytalk UK

12:25 – 13:15
Session 3:

The place to be

The UK has a strong network of biotech hubs, science parks, and innovation hotspots. How do you choose your location to maximise your growth?

Facilitated by:

Bev Vaughan
Arise Innovation Hubs Director, Anglia Ruskin University

Panellists include:

Mayer Schreiber
Chief Executive Officer, Discovery Park

Nuno Alves
Associate Director – Business Development, Astellas Europe

Steven Trim
Director, Venomtech Ltd

Rich Ferrie
Chief Executive Officer, London BioScience Innovation Centre (LBIC)

Kristin Anne Rutter
Executive Director, Cambridge University Health Partners

Networking Lunch

13:15 – 14:15

14:15 – 15:05
Session 4:

Productive partnerships

When time is money, an efficient partnership can be the key to success. What is the key to a healthy partnership between a biotech and CDMO/CMO, and how do partnerships evolve with the changing needs of a growing biotech?

Facilitated by:

Nathalie Huther
Associate Vice President Business Development (CMC),

Panellists include:

Justin Bryans
Chief Scientific Officer (Discovery), Charles River Laboratories

Kevin Cox
Chairman, VALIRX PLC

Helen Barker
Vice President, Global Tech Ops & CMC, Reneo Pharmaceuticals

Kwok Pang
Chief Digital Officer, Adthera Bio

Neil Jones
Chief Commercial Officer, Aenova Group

 

15:10 – 16:00
Session 5:

The workforce of the future

What should the biotech workforce of the future look like? How can we develop new skills and embrace diverse ways of thinking to build a better biotech sector?

Facilitated by:

Hardeep Jhutty
Director of R&D Strategic Operations,

Panellists include:

Claire Pike
Pro Vice-Chancellor (Education Enhancement) and Professor, Anglia Ruskin University

Shadi Farhangrazi
Chief Executive Officer, S.M. Discovery Group (SMDG)

Lydia Mapstone
CEO and Co-founder at BoobyBiome

Philip Probert
Biologics Technology Lead, CPI

Networking Drinks Reception

16:00 – 17:00

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo
Enablers Making it

Anglia Ruskin University, Cambridge

15 May 2024